Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy.

Nat Rev Clin Oncol

Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK.

Published: December 2019

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0285-2DOI Listing

Publication Analysis

Top Keywords

brca mutations
4
mutations tumour-agnostic
4
tumour-agnostic biomarkers
4
biomarkers parp
4
parp inhibitor
4
inhibitor therapy
4
brca
1
tumour-agnostic
1
biomarkers
1
parp
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!